← Back to Search

Saskatoon Berry for Metabolism Enhancement

N/A

Recruiting

Led By Garry Shen, PhD

Research Sponsored by University of Manitoba

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up onset and 10 weeks after the start of dietary intervention

Awards & highlights

Study Summary

This trial will examine the effect of Saskatoon berry on glucose metabolism, insulin resistance, and gut microbiota in healthy adults.

Who is the study for?

This trial is for healthy individuals living in Winnipeg who are willing to sign an informed consent. It's not open to those taking hypoglycemic, anti-hypertensive or lipid-lowering medications, antibiotics within the last month, or with a history of serious metabolic diseases.Check my eligibility

What is being tested?

The study investigates the effects of freeze-dried Saskatoon berry on glucose metabolism, insulin resistance and gut microbiota in healthy adults. This pilot trial aims to explore if this berry can help manage or prevent type 2 diabetes and metabolic syndrome.See study design

What are the potential side effects?

Since Saskatoon berries are natural foods, they may be safer than conventional hypoglycemic medications. However, potential side effects aren't detailed here; typically these could include digestive discomfort.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ onset and 10 weeks after the start of dietary intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~onset and 10 weeks after the start of dietary intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and onset and 10 weeks after the start of dietary intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Glucose tolerance

Gut microbiome

Secondary outcome measures

Blood pressure

Body mass index accord to body weight and height

C-reactive protein

+3 more

Other outcome measures

Dietary intake, physical activities

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single armExperimental Treatment1 Intervention

Single arm

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor

595 Previous Clinical Trials

199,506 Total Patients Enrolled

Diabetes CanadaOTHER

10 Previous Clinical Trials

1,087 Total Patients Enrolled

Garry Shen, PhDPrincipal InvestigatorUniversity of Manitoba

Media Library

Saskatoon berry Clinical Trial Eligibility Overview. Trial Name: NCT04809688 — N/A

Nutritional and Metabolic Disorders Research Study Groups: Single arm

Nutritional and Metabolic Disorders Clinical Trial 2023: Saskatoon berry Highlights & Side Effects. Trial Name: NCT04809688 — N/A

Saskatoon berry 2023 Treatment Timeline for Medical Study. Trial Name: NCT04809688 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial admit participants who are under 30 years of age?

"The upper and lower bounds for patient recruitment stipulate that all participants must be aged 18 or above, with a maximum age of 75."

Answered by AI

What are the prime goals this research endeavor is hoping to achieve?

"The main goal of this dietary trial is to observe changes in the gut microbiome from baseline to 10 weeks after intervention. Secondary outcomes include c-reactive protein (mg/L), tumor necrosis factor-alpha (pg/mL) and liver enzymes ALT and AST levels (units/L)."

Answered by AI

What qualifications must one possess to partake in this medical trial?

"Eligibility criteria for this trial mandates that potential study participants have metabolic and nutrition disorders, as well as being between 18 to 75 years old. Thus far, 20 individuals are registered in the experiment."

Answered by AI

Is this medical experiment welcoming participants at this time?

"According to information on clinicaltrials.gov, this medical study is not taking on new participants at the moment. It was first posted online in eight of January 2023 and last updated thirty-first October 2022. Although no longer actively enrolling patients, there are 124 other trials available for participation immediately."

Answered by AI

Recent research and studies

The Journal of Nutritional BiochemistryJournal

Impact of Saskatoon Berry Powder on Insulin Resistance and Relationship with Intestinal Microbiota in High Fat–high Sucrose Diet-induced Obese Mice

Zhao, Ruozhi, Ehsan Khafipour, Shadi Sepehri, Fei Huang, Trust Beta, and Garry X. Shen. 2019. “Impact of Saskatoon Berry Powder on Insulin Resistance and Relationship with Intestinal Microbiota in High Fat–high Sucrose Diet-induced Obese Mice”. The Journal of Nutritional Biochemistry. Elsevier BV. doi:10.1016/j.jnutbio.2019.03.023.

NutrientsJournal

Saskatoon Berry Amelanchier Alnifolia Regulates Glucose Metabolism and Improves Cardiovascular and Liver Signs of Diet-induced Metabolic Syndrome in Rats

du Preez, Ryan, Stephen Wanyonyi, Peter Mouatt, Sunil K. Panchal, and Lindsay Brown. 2020. “Saskatoon Berry Amelanchier Alnifolia Regulates Glucose Metabolism and Improves Cardiovascular and Liver Signs of Diet-induced Metabolic Syndrome in Rats”. Nutrients. MDPI AG. doi:10.3390/nu12040931.

MicroorganismsJournal

Impact of Cyanidin-3-glucoside on Gut Microbiota and Relationship with Metabolism and Inflammation in High Fat-high Sucrose Diet-induced Insulin Resistant Mice

Huang, Fei, Ruozhi Zhao, Min Xia, and Garry X. Shen. 2020. “Impact of Cyanidin-3-glucoside on Gut Microbiota and Relationship with Metabolism and Inflammation in High Fat-high Sucrose Diet-induced Insulin Resistant Mice”. Microorganisms. MDPI AG. doi:10.3390/microorganisms8081238.

clinicaltrials.govStudy